DrugJul 31, 2019
Temozolomide Capsules, 180 mg recall — FDA D-1512-2019
CGMP Deviations: product was manufactured that did not prevent possible cross contamination with beta lactam products.
Class IIFDA: TerminatedDeva Holding AS - Cerkezkoy Subesi
Recall history in this database
Classification mix: Class II: 6.
DrugJul 31, 2019
Temozolomide Capsules, 100 mg recall — FDA D-1510-2019
CGMP Deviations: product was manufactured that did not prevent possible cross contamination with beta lactam products.
Class IIFDA: TerminatedDeva Holding AS - Cerkezkoy Subesi
DrugJul 31, 2019
Temozolomide Capsules, 20 mg recall — FDA D-1509-2019
CGMP Deviations: product was manufactured that did not prevent possible cross contamination with beta lactam products.
Class IIFDA: TerminatedDeva Holding AS - Cerkezkoy Subesi
DrugJul 31, 2019
Temozolomide Capsules, 250 mg, 5-count bottle recall — FDA D-1513-2019
CGMP Deviations: product was manufactured that did not prevent possible cross contamination with beta lactam products.
Class IIFDA: TerminatedDeva Holding AS - Cerkezkoy Subesi
DrugJul 31, 2019
Temozolomide Capsules, 140 mg recall — FDA D-1511-2019
CGMP Deviations: product was manufactured that did not prevent possible cross contamination with beta lactam products.
Class IIFDA: TerminatedDeva Holding AS - Cerkezkoy Subesi
DrugJul 31, 2019
Temozolomide Capsules, 5 mg recall — FDA D-1508-2019
CGMP Deviations: product was manufactured that did not prevent possible cross contamination with beta lactam products.
Class IIFDA: TerminatedDeva Holding AS - Cerkezkoy Subesi
Understanding this recall history
This page summarizes recall records in which the official source identifies Deva Holding AS - Cerkezkoy Subesi as the recalling firm or manufacturer. The number of records should not be treated as a safety rating or a measure of company size, because recall counts depend on product mix, reporting periods and how government records are organized.
Compare the dates, categories and classifications together rather than relying on the total alone. Open an individual record for the recalled product, reason, distribution details and current instructions available from the source.